TRINITY EXPANDS GLOBAL FOOTPRINT WITH ACQUISITION OF EVERSANA’S APACME ADVISORY SERVICES

WALTHAM, Mass., Nov 3 (Bernama) -- November 3, 2025 - Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME).

The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further advancing Trinity’s mission to empower life sciences organizations across the globe with tech-enabled strategy, insights, and analytics. It also marks a new era for Trinity, as the company expands its integrated portfolio to deliver greater impact for pharmaceutical, biotech, and medtech companies worldwide, deepening its expertise and local presence in APACME—a rapidly growing region for life sciences innovation. The acquisition expands Trinity’s global presence in Singapore, Tokyo, Mumbai, Shanghai, Sydney, and Dubai, following its July 2025 opening of its Mexico City office.